Early visuospatial deficits predict the occurrence of visual hallucinations in autopsy-confirmed dementia with Lewy bodies.

OBJECTIVES The current study explored the value of visuospatial findings for predicting the occurrence of visual hallucinations (VH) in a sample of patients with dementia with Lewy bodies (DLB) compared with patients with Alzheimer disease (AD). PARTICIPANTS/MEASUREMENTS: Retrospective analysis of 55 autopsy-confirmed DLB and 55 demographically similar, autopsy-confirmed AD cases determined whether severe initial visuospatial deficits on the WISC-R Block Design subtest predicted the development of VH. Visuospatial deficits were considered severe if Block Design z scores were 2.5 or more standard deviations below the mean of a well-characterized normal control group (severe visuospatial deficits [severe-VIS]; DLB: n = 35, AD: n = 26) and otherwise were considered mild (mild visuospatial deficits [mild-VIS]; DLB: n = 20, AD: n = 29). RESULTS Forty percent of the severe-VIS DLB group had baseline VH compared with 0% of mild-VIS DLB patients. Only 8% of the severe-VIS and 3% mild-VIS AD patients had baseline VH. During the follow-up period (mean = 5.0 years), an additional 61% of the severe-VIS but only 11% of the mild-VIS DLB patients developed VH. In that period, 38% of the severe-VIS and 20% of the mild-VIS AD patients developed VH. After considering initial MMSE score and rate of decline, logistic regression analyses found that performance on Block Design significantly predicted the presence of VH in the DLB group but not the AD group. CONCLUSIONS The presence of early, severe deficits on neuropsychological tests of visuospatial skill increases the likelihood that patients with suspected DLB will develop the prototypical DLB syndrome. The presence of such deficits may identify those DLB patients whose syndrome is driven by α-synuclein pathology rather than AD pathology and may inform treatment plans as well as future research.

[1]  Charles D. Smith,et al.  Low sensitivity in clinical diagnoses of dementia with Lewy bodies , 2010, Journal of Neurology.

[2]  E. De Rosa,et al.  Cholinergic Deafferentation of the Neocortex Using 192 IgG-Saporin Impairs Feature Binding In Rats , 2009, The Journal of Neuroscience.

[3]  L. Thal,et al.  Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies. , 2008, Neuropsychology.

[4]  E. De Rosa,et al.  A Cross-Species Investigation of Acetylcholine, Attention, and Feature Binding , 2008, Psychological science.

[5]  E. De Rosa,et al.  Cholinergic influences on feature binding. , 2007, Behavioral neuroscience.

[6]  M. Onofrj,et al.  Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium , 2006, Neurology.

[7]  L. Thal,et al.  What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? , 2006, Brain : a journal of neurology.

[8]  E. Perry,et al.  Why people see things that are not there: A novel Perception and Attention Deficit model for recurrent complex visual hallucinations , 2005, Behavioral and Brain Sciences.

[9]  U P Mosimann,et al.  Visual perception in Parkinson disease dementia and dementia with Lewy bodies , 2004, Neurology.

[10]  G. Glover,et al.  Altered cortical visual processing in PD with hallucinations , 2004, Neurology.

[11]  R. van Reekum,et al.  Visuospatial impairment in dementia with Lewy bodies and Alzheimer's disease: a process analysis approach , 2003, International journal of geriatric psychiatry.

[12]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[13]  L. Thal,et al.  Alzheimer’s disease can be accurately diagnosed in very mildly impaired individuals , 2002, Neurology.

[14]  J. Hodges,et al.  Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[15]  Bonnet Am [The Unified Parkinson's Disease Rating Scale]. , 2000 .

[16]  E. Mori,et al.  Visuoperceptual impairment in dementia with Lewy bodies. , 2000, Archives of neurology.

[17]  E. Perry,et al.  Acetylcholine in mind: a neurotransmitter correlate of consciousness? , 1999, Trends in Neurosciences.

[18]  R. Terry,et al.  Position Paper on Diagnostic Criteria for Alzheimer Disease , 1997, Neurobiology of Aging.

[19]  M. Voytko Cognitive functions of the basal forebrain cholinergic system in monkeys: memory or attention? , 1996, Behavioural Brain Research.

[20]  J. Muir,et al.  Excitotoxic lesions of basal forebrain cholinergic neurons: Effects on learning, memory and attention , 1993, Behavioural Brain Research.

[21]  M. D. O'Brien,et al.  Cerebral blood flow in dementia , 1986, Neurology.

[22]  R. DeTeresa,et al.  Some morphometric aspects of the brain in senile dementia of the alzheimer type , 1981, Annals of neurology.

[23]  W. Sturm,et al.  Neuropsychological assessment , 2007, Journal of Neurology.

[24]  A. Benton,et al.  Clinical Evaluation of Visual Perception and Constructional Ability. , 2006 .

[25]  P. Snyder,et al.  Clinical neuropsychology: A pocket handbook for assessment, 2nd ed. , 2006 .

[26]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.

[27]  K. Jellinger,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.

[28]  S. Fahn Unified Parkinson's Disease Rating Scale , 1987 .